Therefore, the rationale for conducting this study is to evaluate whether the administration of a single dose of Palonosetron combined with Dexamethasone is superior to a single dose of Palonosetron alone in the prevention of both immediate and delayed PONV in high risk patients undergoing laparoscopic abdominal or gynecologic surgery.